Home › Calculator › BCLI Dividend Calculator 2026
BCLI Dividend Calculator 2026
No dividendHealthcareBrainstorm Cell Therapeutics Inc. · OTC
Price: $0.82 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
BCLI is not a dividend-focused stock
BCLI pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
BCLI Dividend Yield
Brainstorm Cell Therapeutics Inc. (BCLI) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BCLI pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Brainstorm Cell Therapeutics Inc. (BCLI) — Dividend Analysis 2026
Brainstorm Cell Therapeutics Inc. (BCLI) is a biotechnology firm dedicated to the development and commercialization of personalized, autologous cellular therapies. These innovative treatments are specifically designed to address neurodegenerative diseases. At the heart of its strategy is the proprietary NurOwn cell therapy platform. This platform employs sophisticated cell culture techniques to prompt mesenchymal stem cells, derived from the patient's own bone marrow, to produce high concentrations of neurotrophic factors. This process aims to regulate neuroinflammatory and neurodegenerative disease mechanisms, bolster the survival of neurons, and ultimately enhance neurological function. NurOwn is currently undergoing significant clinical development, having completed a Phase III clinical trial for Amyotrophic Lateral Sclerosis (ALS). Additionally, it has successfully advanced through Phase II clinical trials for both progressive multiple sclerosis and Alzheimer's disease, with potential applications being explored for other neurodegenerative conditions. To support its therapeutic pipeline, the company has established a manufacturing partnership with Catalent for NurOwn. Incorporated in 2000, the company initially operated as Golden Hand Resources Inc. before adopting the name Brainstorm Cell Therapeutics Inc. in November 2004. Its corporate headquarters are situated in New York, New York.
BCLI Dividend & DRIP — Frequently Asked Questions
Does BCLI pay a dividend?
No. Brainstorm Cell Therapeutics Inc. (BCLI) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of BCLI?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does BCLI have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. BCLI has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to BCLI
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BCLI DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BCLI position with:
🌍 BCLI Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BCLI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BCLI Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BCLI Dividend Payment Schedule
BCLI pays quarterly — 4 times per year. Ex-div: —.
📊 BCLI vs Healthcare Benchmarks
How BCLI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BCLI sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BCLI Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-24 | 100,000 | — | — | ||
| A-Award | 2026-07-24 | 900,000 | $1.00 | $900.0K | ||
| Other | 2026-05-25 | 150,000 | $0.68 | $102.0K | ||
| A-Award | 2026-02-26 | 1,800,000 | — | — | ||
| A-Award | 2026-02-26 | 150,000 | — | — | ||
| A-Award | 2026-02-26 | 100,000 | — | — | ||
| A-Award | 2026-02-26 | 200,000 | — | — | ||
| A-Award | 2026-02-26 | 120,000 | — | — | ||
| A-Award | 2026-02-26 | 150,000 | $0.70 | $105.0K | ||
| A-Award | 2026-02-26 | 150,000 | $0.70 | $105.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare BCLI with peers: BCLI vs ACXP · BCLI vs ADIL · BCLI vs ADXN
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BCLI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Brainstorm Cell Therapeutics Inc. (BCLI) is currently trading at $0.82, 51% below its 52-week high. It does not currently pay a regular dividend.
Does BCLI Pay a Dividend? Brainstorm Cell Therapeutics Inc. Dividend Status
Brainstorm Cell Therapeutics Inc. (BCLI) is a healthcare stock trading at $0.82. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BCLI News
LiveProjected your BCLI DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.